Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis

Experimental Cell Research

Volumn 318, Issue 17, 2012, Pages 2215-2225

  Jandova, Jana ^a   Janda, Jaroslav ^a   Sligh, James E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Gene expression; Microarrays; Migration and invasion; MMP 9; MtDNA mutation; Reactive oxygen species

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ANGIOPOIETIN; BULLOUS PEMPHIGOID ANTIGEN 1; CD28 ANTIGEN; COLLAGEN TYPE 1; CYCLIN D1; CYTOCHROME C OXIDASE; DIHYDROFOLATE REDUCTASE; GELATINASE B; GLUCOSAMINE PHOSPHATE ACETYLTRANSFERASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; ILOMASTAT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; ISOPENTENYL DIPHOSPHATE DELTA ISOMERASE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MITOCHONDRIAL DNA; NICOTINAMIDE METHYLTRANSFERASE; PEPTIDYLPROLYL ISOMERASE; PROTEIN LYSINE 6 OXIDASE; PROTEIN MD 2; RANTES; STAT2 PROTEIN; STEROL 14ALPHA DEMETHYLASE; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYBRID; ENZYME ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC CODE; ION TRANSPORT; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SKIN TUMOR; UNINDEXED SEQUENCE;

MURINAE; MUS;

EID: 84864820611     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.06.006     Document Type: Article

References (44)

1. Copeland W.C., Wachsman J.T., Johnson F.M., Penta J.S. Mitochondrial DNA alterations in cancer. Cancer Invest. 2002, 20:557-569.
2. Verma M., Kumar D. Application of mitochondrial genome information in cancer epidemiology. Clin. Chim. Acta 2007, 383:41-50.
3. Polyak K., Li Y.B., Zhu H., Lengauer C., Willson J.K.V., Markowitz S.D., Trush M.A., Kinzler K.W., Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 1998, 20:291-293.
4. Alonso A., Martin P., Albarran C., Aguilera B., Garcia O., Guzman A., Oliva H., Sancho M. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 1997, 18:682-685.
5. Birch-Machin M.A. The role of mitochondria in ageing and carcinogenesis. Clin. Exp. Dermatol. 2006, 31:548-552.
6. Eshaghian A., Vleugels R.A., Canter J.A., McDonald M.A., Stasko T., Sligh J.E. Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers. J. Invest. Dermatol. 2006, 126:336-344.
7. Fliss M.S., Usadel H., Cabellero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000, 287:2017-2019.
8. Gasparre G., Lommarini L., Porcelli A.M., Lang M., Ferri G.G., Kurelac I., Zuntini R., Mariani E., Pennisi L.F., Pasquini E., Pasquinelli G., Ghelli A., Bonora E., Ceccarelli C., Rugolo M., Salfi N., Romeo G., Carelli V. An inherited mitochondrial dna disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum. Mutat. 2009, 30:391-396.
9. Gasparre G., Porcelli A.M., Bonora E., Pennisi L.F., Toller M., Iommarini L., Ghelli A., Moretti M., Betts C.M., Martinelli G.N., Ceroni A.R., Curcio F., Carelli V., Rugolo M., Tallini G., Romeo G. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc. Natl. Acad Sci. USA. 2007, 104:9001-9006.
10. Horton T.M., Petros J.A., Heddi A., Shoffner J., Kaufman A.E., Graham S.D., Gramlich T., Wallace D.C. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Gene Chromosome Cancer 1996, 15:95-101.
11. Mayr J.A., Meierhofer D., Zimmermann F., Feichtinger R., Kogler C., Ratschek M., Schmeller N., Sperl W., Kofler B. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin. Cancer Res. 2008, 14:2270-2275.
12. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., Lim S., Issa M.M., Flanders W.D., Hosseini S.H., Marshall F.F., Wallace D.C. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA 2005, 102:719-724.
13. Porcelli A.M., Ghelli A., Ceccarelli C., Lang M., Cenacchi G., Capristo M., Pennisi L.F., Morra I., Ciccarelli E., Melcarne A., Bartoletti-Stella A., Salfi N., Tallini G., Martinuzzi A., Carelli V., Attimonelli M., Rugolo M., Romeo G., Gasparre G. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum. Mol. Genet. 2010, 19:1019-1032.
14. Tan D.J., Bai R.K., Wong L.J.C. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62:972-976.
15. Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., Leigh I., Gorman P., Lamlum H., Rahman S., Roylance R.R., Olpin S., Bevan S., Barker K., Hearle N., Houlston R.S., Kiuru M., Lehtonen R., Karhu A., Vilkki S., Laiho P., Eklund C., Vierimaa O., Aittomaki K., Hietala M., Sistonen P., Paetau A., Salovaara R., Herva R., Launonen V., Aaltonen L.A. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002, 30:406-410.
16. Toro J.R., Nickerson M.L., Wei M.H., Warren M.B., Glenn G.M., Turner M.L., Stewart L., Duray P., Tourre O., Sharma N., Choyke P., Stratton P., Merino M., Walther M.M., Linehan W.M., Schmidt L.S., Zbar B. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am. J. Hum. Genet. 2003, 73:95-106.
17. Zimmermann F.A., Mayr J.A., Neureiter D., Feichtinger R., Alinger B., Jones N.D., Eder W., Sperl W., Kofler B. Lack of complex I is associated with oncocytic thyroid tumours. Br. J. Cancer 2009, 100:1434-1437.
18. Jandova J., Eshaghian A., Shi M., Li M., King L.E., Janda J., Sligh J.E. Identification of an mtDNA mutation hot spot in UV-induced mouse skin tumors producing altered cellular biochemistry. J. Invest. Dermatol. 2012, 132:421-428.
19. Jandova J., Shi M., Norman K.G., Stricklin G.P., Sligh J.E. Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype. Biochim. Biophys. Acta 2012, 1822:293-300.
20. Marin-Garcia J., Pi Y., Goldenthal M.J. Mitochondrial-nuclear cross-talk in the aging and failing heart. Cardiovasc. Drug Ther. 2006, 20:477-491.
21. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett. 2008, 266:53-59.
22. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
23. Kawasaki K., Suzuki T., Ueda M., Ichihashi M., Reguer G., Yamasaki H. CC to TT mutation in the mitochondrial DNA of normal skin: relationship to ultraviolet light exposure. Mutat. Res. Genet. Toxcol. Environ. 2000, 468:35-43.
24. Shen Z.Z., Wu W.J., Hazen S.L. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry-US. 2000, 39:5474-5482.
25. Yakes F.M., VanHouten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 1997, 94:514-519.
26. Lenaz G., D'Aurelio M., Pich M.M., Geneva M.L., Ventura B., Bovina C., Formiggini G., Castelli G.P. Mitochondrial bioenergetics in aging. Bba-Bioenergetics 2000, 1459:397-404.
27. Hitchler M.J., Domann F.E. An epigenetic perspective on the free radical theory of development. Free Radical Bio. Med. 2007, 43:1023-1036.
28. Wallace D.C., Fan W.W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010, 10:12-31.
29. Trounce I., Wallace D.C. Production of transmitochondrial mouse cell lines by cybrid rescue of rhodamine-6G pre-treated L-cells. Somatic Cell and Mol. Genet. 1996, 22:81-85.
30. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., Nakada K., Honma Y., Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008, 320:661-664.
31. Danielson S.R., Carelli V., Tan G., Martinuzzi A., Schapira A.H., Savontaus M.L., Cortopassi G.A. Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process. Brain 2005, 128:1026-1037.
32. Deyholos M.K., Galbraith D.W. High-density microarrays for gene expression analysis. Cytometry 2001, 43:229-238.
33. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene-expression patterns with a complementary-DNA microarray. Science 1995, 270:467-470.
34. Imaoka T., Yamashita S., Nishimura M., Kakinuma S., Ushijima T., Shimada Y. Gene expression profiling distinguishes between spontaneous and radiation-induced rat mammary carcinomas. J. Radiat. Res. 2008, 49:349-360.
35. Aung C.S., Hill M.M., Bastiani M., Parton R.G., Parat M.O. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9. Eur. J. Cell Biol. 2011, 90:136-142.
36. Beeghly-Fadiel A., Lu W., Shu X.O., Long J.R., Cai Q.Y., Xiang Y.B., Gao Y.T., Zheng W. MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Breast Cancer Res. Treat. 2011, 126:507-513.
37. Zhu K.Q., Carrougher G.J., Couture O.P., Tuggle C.K., Gibran N.S., Engrav L.H. Expression of collagen genes in the cones of skin in the Duroc/Yorkshire porcine model of fibroproliferative scarring. J. Burn Care Res. 2008, 29:815-827.
38. Collier I.E., Legant W., Marmer B., Lubman O., Saffarian S., Wakatsuki T., Elson E., Goldberg G.I. Diffusion of MMPs on the surface of collagen fibrils: the mobile cell surface-collagen substratum interface. PLoS One 2011, 6:e24029.
39. Stellas D., El Hamidieh A., Patsavoudi E. Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. Bmc Cell Biol. 2010, 11.
40. Y. Sun, L.J. Dong, Role of matrix metalloproteinases in the pathogenesis and therapy of leukemia, Zhongguo Shi., Yan Xue., Ye Xue., Za Zhi., 11 (2003) 316-320.
41. Peng C.W., Liu X.L., Liu X., Li Y. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J. Transl. Med. 2010, 8.
42. Annunziata C.M., Stavnes H.T., Kleinberg L., Berner A., Hernandez L.F., Birrer M.J., Steinberg S.M., Davidson B., Kohn E.C. Nuclear factor kappa B transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer-Am. Cancer Soc. 2010, 116:3276-3284.
43. Richmond A., NF-kappa B. Chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2002, 2:664-674.
44. Tobar N., Villar V., Santibanez J.F. ROS-NF kappa I' mediates TGF-beta 1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol. Cell Biochem. 2010, 340:195-202.